Drug Shortage Report for FEIBA NF
Report ID | 140469 |
Drug Identification Number | 02353903 |
Brand name | FEIBA NF |
Common or Proper name | ANTI INHIBITOR COAGULANT COMPLEX |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ANTI-INHIBITOR COAGULANT COMPLEX |
Strength(s) | 3250UNIT |
Dosage form(s) | KIT POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | Labelled 2500 U 100mL Vial |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-06-04 |
Actual start date | 2021-06-04 |
Estimated end date | 2021-06-30 |
Actual end date | 2021-06-29 |
Shortage status | Resolved |
Updated date | 2021-06-30 |
Company comments | Resolved |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-06-30 | French | Compare |
v5 | 2021-06-30 | French | Compare |
v4 | 2021-06-30 | English | Compare |
v3 | 2021-06-05 | English | Compare |
v2 | 2021-06-04 | French | Compare |
v1 | 2021-06-04 | English | Compare |
Showing 1 to 6 of 6